Multiple Myeloma
News
The Prognostic Value of Circulating Plasma Cells in Multiple Myeloma
A meta-analysis of 11 different studies was performed to determine whether circulating plasma cells are useful in the prognosis of patients...
News
A New ‘Triplet’ Treatment for Multiple Myeloma
A combination of 3 different types of inhibitors has recently been shown to be effective in the treatment of patients with multiple myeloma...
Conference Coverage
Novel CAR T cells drive high objective response rate in multiple myeloma
CHICAGO – CARs just keep getting better, with a new target for multiple myeloma.
Conference Coverage
Smoldering myeloma progressed more rapidly in patients with elevated BMIs
An elevated body mass index appears to be a risk factor for progression of smoldering multiple myeloma, according to Wilson I. Gonsalves, MD, and...
Conference Coverage
Myeloma patients who get solid tumor cancers do as well as other cancer patients
With improved treatment, patients with multiple myeloma are surviving long enough to develop other cancers, Jorge J. Castillo, MD, and Adam J....
Conference Coverage
Lenalidomide maintenance boosted depth of response in myeloma patients
Lenalidomide maintenance therapy further improved depth of response in newly diagnosed, transplant-eligible patients with multiple myeloma in the...
Article
Multiple Myeloma: Updates on Diagnosis and Management
Two- and 3-drug treatment regimens and autologous stem cell transplants provide
opportunities for longer term disease remission, though most...
News
Transplantation plus VRD tops VRD alone in myeloma
High-dose chemotherapy and autologous stem cell transplantation plus bortezomib, lenalidomide, and dexamethasone (VRD) outperformed consolidation...
Article
Diagnosing Gastric Plasmacytoma
Researchers rule out possible diagnoses with extensive process of elimination to correctly diagnose a rare cancer.
News
New approach for monitoring minimum residual disease in multiple myeloma
Next-generation sequencing might be useful to monitor for minimum residual disease in multiple myeloma.